NPI: 1801947668 · PORTLAND, OR 97209 · Substance Use Disorder Rehabilitation Clinic/Center · NPI assigned 01/16/2007
Authorized official FARLEY, BRIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | FARLEY, BRIAN (VP & SECRETARY) |
| Parent Organization | ACADIA HEALTHCARE COMPANY, INC. |
| NPI Enumeration Date | 01/16/2007 |
Other providers sharing the same authorized official: FARLEY, BRIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 382,881 | $5.11M |
| 2019 | 474,430 | $5.89M |
| 2020 | 399,947 | $4.66M |
| 2021 | 153,774 | $2.78M |
| 2022 | 190,268 | $2.60M |
| 2023 | 145,232 | $3.58M |
| 2024 | 117,849 | $2.97M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 208,102 | 99,218 | $8.95M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1,322,079 | 62,552 | $8.38M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 76,973 | 52,144 | $5.43M |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 156,895 | 58,808 | $3.44M |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 4,578 | 4,497 | $377K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 25,349 | 1,334 | $298K |
| J0571 | Buprenorphine, oral, 1 mg | 16,684 | 741 | $203K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 32,291 | 2,719 | $166K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,803 | 1,667 | $142K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,047 | 976 | $101K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 5,611 | 548 | $41K |
| H0001 | Alcohol and/or drug assessment | 188 | 187 | $28K |
| H0033 | Oral medication administration, direct observation | 2,079 | 279 | $20K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 6,707 | 1,901 | $18K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 97 | 88 | $6K |
| J3490 | Unclassified drugs | 645 | 35 | $4K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 3,034 | 1,234 | $917.81 |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 219 | 114 | $428.00 |